Cite

HARVARD Citation

    Ademi, Z. et al. (2016). Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective. Medicine. 95 (18), pp. e3531-. [Online]. 
  
Back to record